Heparin-coated cardiopulmonary bypass circuit: Clinical effects in pediatric cardiac surgery

被引:16
|
作者
Miyaji, K [1 ]
Hannan, RL [1 ]
Ojito, J [1 ]
Jacobs, JP [1 ]
White, JA [1 ]
Burke, RP [1 ]
机构
[1] Miami Childrens Hosp, Dept Cardiovasc Surg, Miami, FL USA
关键词
D O I
10.1111/j.1540-8191.2000.tb00456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Heparin-coated cardiopulmonary bypass (CPB) circuits have been reported to reduce complement activation and the inflammatory response associated with CPB. We retrospectively compared patients utilizing heparin-coated perfusion circuits with those using noncoated circuits to determine the clinical effects of the different circuits in pediatric cardiac surgery. Methods: Between July 1995 and July 1997, 203 patients weighing < 10 kg underwent cardiac surgery, 153 patients using heparin-coated bypass circuits and 50 patients using noncoated circuits. The 50 patients operated on with the noncoated circuit (Group N) were matched to 100 patients operated on with coated circuits (Group H) in age, weight, and type of procedure. Urine output during bypass, blood products used after bypass, postoperative ventilation days, hospital stay, morbidity, and mortality were compared between these groups. Results: Body weight, perfusion time, and procedure time were not different between the two groups. Urine output during bypass was notably greater in Group H than in Group hi (11.3 +/- 10.5 mL/kg per hour vs 4.8 +/- 3.1 mL/kg per hour, respectively, p < 0.0001). Postoperative mechanical ventilation markedly decreased in Group H (Group H vs hi = 2.8 +/- 2.7 days vs 5.1 +/- 7.5 days, respectively, p < 0.05). Red blood cell usage, hospital stay, morbidity, and mortality were not statistically different, although there was a tendency toward decreased transfusion of red cell and platelets in Group H (Group H vs N = 61.2 +/- 121.1 mL/kg vs 102.0 +/- 176.7 mL/kg, respectively, in red cell, p = 0.15; and Group H vs hi = 7.9 +/- 13.7 mL/kg vs 13.2 +/- 24.5 mL/kg, respectively, in platelets, p = 0.16). Conclusions: Patients operated on with the use of heparin-coated circuits had increased urine output during bypass and required less time postoperatively on the ventilator. These results suggest a reduction in the acute inflammatory response, capillary leakage, and overall systemic edema. We now routinely use coated circuits on all pediatric pump cases.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [41] HEPARIN-COATED CARDIOPULMONARY BYPASS CIRCUITS AND 25-PERCENT REDUCTION OF HEPARIN DOSE IN CORONARY-ARTERY SURGERY - A CLINICAL-STUDY
    BOROWIEC, J
    THELIN, S
    BAGGE, L
    VANDERLINDEN, J
    THORNO, E
    HANSSON, HE
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1992, 97 (01) : 55 - 66
  • [42] CASE 5 - 1996 - Thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia
    VanDyck, MJ
    LavennePardonge, E
    Azerad, MA
    Matta, AG
    Moriau, M
    Comunale, ME
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (06) : 809 - 815
  • [43] EFFECTS ON COAGULATION AND FIBRINOLYSIS WITH REDUCED VERSUS FULL SYSTEMIC HEPARINIZATION AND HEPARIN-COATED CARDIOPULMONARY BYPASS
    OVRUM, E
    BROSSTAD, F
    HOLEN, EA
    TANGEN, G
    ABDELNOOR, M
    CIRCULATION, 1995, 92 (09) : 2579 - 2584
  • [44] Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation
    Ovrum, E
    Fosse, E
    Mollnes, TE
    Holen, EA
    Tangen, G
    Abdelnoor, M
    Ringdal, MAL
    Oystese, R
    Venge, P
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1996, 10 (01) : 54 - 60
  • [45] Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass
    Tamim, M
    Demircin, E
    Guvener, M
    Peker, O
    Yilmaz, M
    PANMINERVA MEDICA, 1999, 41 (03) : 193 - 198
  • [46] Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass
    Lundblad, R
    Moen, O
    Fosse, E
    ANNALS OF THORACIC SURGERY, 1997, 63 (05): : 1361 - 1367
  • [47] Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits
    Ernofsson, M
    Thelin, S
    Siegbahn, A
    SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 29 (04): : 157 - 165
  • [48] REDUCED GRANULOCYTE ACTIVATION WITH A HEPARIN-COATED DEVICE IN AN INVITRO MODEL OF CARDIOPULMONARY BYPASS
    VIDEM, V
    NILSSON, L
    VENGE, P
    SVENNEVIG, JL
    ARTIFICIAL ORGANS, 1991, 15 (02) : 90 - 95
  • [49] DISPARITY IN BLOOD ACTIVATION BY 2 DIFFERENT HEPARIN-COATED CARDIOPULMONARY BYPASS SYSTEMS
    MOEN, O
    FOSSE, E
    BROCKMEIER, V
    ANDERSSON, C
    MOLLNES, TE
    HOGASEN, K
    VENGE, P
    ANNALS OF THORACIC SURGERY, 1995, 60 (05): : 1317 - 1323
  • [50] HEPARIN-COATED EQUIPMENT REDUCES COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS IN THE PIG
    NILSSON, L
    STORM, KE
    THELIN, S
    BAGGE, L
    HULTMAN, J
    THORELIUS, J
    NILSSON, U
    ARTIFICIAL ORGANS, 1990, 14 (01) : 46 - 48